Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (95)	2/16/2000 8:16:00 PM
From: N/E PATSFAN	Read Replies (2) \| Respond to of 1833

[OSIP News] Rick, aren't you disappointed with KDUS's performance today based on the licensing agreement with OSIP (other than the increase in value to your "stake" in OSIP)? If KDUS retained the rights for further licensing why wasn't it rewarded unless the perception is that the fees weren't very lucrative? Disclosure > I haven't bot KDUS yet and now wonder if OSIP isn't the better play esp @ lower prices. Prefer to buy KDUS {more leverage} if you think they will eventually be a winner - btw, is the current business plan to license assets to build cash for other products? Regards, ? and the Mysterians